Article Information
History
- December 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nirav Thosani1,
- Putao Cen2,
- Julie Rowe2,
- Sushovan Guha1,
- Jennifer Bailey-Lundberg1,
- Dimpal Bhakta1,
- Prithvi Patil1,
- Shahrooz Rashtak1,
- Roy Tomas Davee1,
- Srinivas Ramireddy1 and
- Curtis J. Wray3,*
- 1University of Texas Health Science Center at Houston, McGovern Medical School, Department of Medicine, Division of Gastroenterology, Houston, Texas
- 2University of Texas Health Science Center at Houston, Department of Medicine, Division of Oncology, McGovern Medical School, Houston, Texas
- 3University of Texas Health Science Center at Houston, Department of Surgery, Houston, Texas
- ↵*Corresponding Author: Curtis J. Wray, MD MS, Professor of Surgery, University of Texas Medical School at Houston, 6431 Fannin Street, MSB 4.164a, Houston, Texas 77030; email: curtis.j.wray{at}uth.tmc.edu
Posted December 14, 2021.
LONG-TERM OUTCOMES OF ENDOSCOPIC ULTRASOUND-GUIDED RADIOFREQUENCY ABLATION (EUS-RFA) FOR ADVANCED PANCREATIC AND PERIAMPULLARY ADENOCARCINOMA
